Full history for every metric is available with a Kvantra account
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $bn | 122 | 139 | 157 | 171 | 177 | 199 | 202 | 200 |
| Operating profit | $bn | 8.11 | 7.46 | ||||||
| Net profit | $bn | 4.57 | 6.10 | 5.89 | 5.99 | 5.98 | 5.66 | 5.14 | 6.37 |
| EPS reported | $ | 25.12 | 23.45 | ||||||
| Operating cashflow per share | $ | 19.34 | 34.91 | ||||||
| Capex per share | $ | 5.03 | 4.97 | ||||||
| FCF per share | $ | 14.31 | 29.94 | ||||||
| Free cash flow | $bn | 3.17 | 6.51 | ||||||
| Net debt | $bn | 23.2 | -7.1 | ||||||
| Book value equity | $bn | 43.9 | 44.7 | ||||||
| Book value per share | $ | 197.8 | 205.3 | ||||||
| Number of shares | m | 221.8 | 217.6 | ||||||
| DPS (TTM paid) | $ | 6.84 | 6.87 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 13.96 | 18.31 | ||||||
| P/B LTM | x | 1.77 | 2.08 | ||||||
| P/S LTM | x | 0.39 | 0.46 | ||||||
| P/FCF LTM | x | 24.50 | 14.24 | ||||||
| EV/EBITDA LTM | x | 10.51 | 9.66 | ||||||
| EV/Sales LTM | x | 0.51 | 0.42 | ||||||
| Earnings Yield LTM | % | 7.16% | 5.46% | ||||||
| FCF Yield | % | 4.08% | 7.02% | ||||||
| Quality | |||||||||
| ROE | % | 12.90% | 11.59% | ||||||
| ROIC | % | 6.65% | 7.47% | ||||||
| Operating margin | % | 4.07% | 3.69% | ||||||
| Gross margin | % | 25.56% | 36.55% | ||||||
| FCF/Sales | % | 1.59% | 3.23% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | -2.18% | -4.13% | ||||||
| Sales Growth YoY | % | +12.62% | +3.60% | ||||||
| Net Income Growth YoY | % | -5.32% | -7.12% | ||||||
| FCF Growth | % | -30.27% | +72.92% | ||||||
| Operating Profit Growth | % | -8.73% | -12.03% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 1.97% | 1.60% | ||||||
| Dividend Growth | % | +4.91% | +1.63% | ||||||
| Payout Ratio | % | 27.44% | 29.13% | ||||||
| FCF/Debt | x | 0.10 | 0.21 | ||||||
| Net Debt/EBITDA | x | 2.46 | 2.30 | ||||||
| EBIT/Net interest | x | 5.79 | 6.56 | ||||||
| Net debt/market cap | % | 29.86% | -7.64% | ||||||
| Net debt/Equity | x | 0.53 | -0.16 | ||||||
| Gross debt/equity | x | 0.76 | 0.69 | ||||||
ETFs that hold Elevance Health
| Fund | Ticker | Position# | Weight |
|---|---|---|---|
| First Eagle Global Equity ETF | FEGE | 7 | 1.83% |
| iShares U.S. Healthcare Providers ETF | IHF | 3 | 9.55% |
| iShares Morningstar Mid-Cap Value ETF | IMCV | 9 | 1.24% |
| Oakmark U.S. Large Cap ETF | OAKM | 7 | 3.29% |
| Tidal Trust III - The BeeHive ETF | BEEX | 5 | 3.83% |
| Invesco Actively Managed Exchange Traded Fund Trust - Invesco Comstock Contrarian Equity ETF | CSTK | 8 | 2.56% |
| CresAlta Global Dividend ETF | CVGD | 2 | 3.96% |
| Monarch Volume Factor Dividend Tree ETF | MVFD | 8 | 2.84% |
| Cambiar Aggressive Value ETF | CAMX | 1 | 4.98% |
| Dana Concentrated Dividend ETF | DIVE | 6 | 4.65% |
Funds with Elevance Health among their ten largest holdings, largest fund first.
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
| Fund | Ticker | Position# | Weight |
|---|---|---|---|
| First Eagle Global Equity ETF | FEGE | 7 | 1.83% |
| iShares U.S. Healthcare Providers ETF | IHF | 3 | 9.55% |
| iShares Morningstar Mid-Cap Value ETF | IMCV | 9 | 1.24% |
| Oakmark U.S. Large Cap ETF | OAKM | 7 | 3.29% |
| Tidal Trust III - The BeeHive ETF | BEEX | 5 | 3.83% |
| Invesco Actively Managed Exchange Traded Fund Trust - Invesco Comstock Contrarian Equity ETF | CSTK | 8 | 2.56% |
| CresAlta Global Dividend ETF | CVGD | 2 | 3.96% |
| Monarch Volume Factor Dividend Tree ETF | MVFD | 8 | 2.84% |
| Cambiar Aggressive Value ETF | CAMX | 1 | 4.98% |
| Dana Concentrated Dividend ETF | DIVE | 6 | 4.65% |
Funds with Elevance Health among their ten largest holdings, largest fund first.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free